Maze Therapeutics, Inc. (MAZE)
MAZE Stock Price Chart
Explore Maze Therapeutics, Inc. interactive price chart. Choose custom timeframes to analyze MAZE price movements and trends.
MAZE Company Profile
Discover essential business fundamentals and corporate details for Maze Therapeutics, Inc. (MAZE) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
31 Jan 2025
Employees
125.00
Website
https://www.mazetx.comCEO
Jason V. Coloma M.P.H.,
Description
Maze Therapeutics, Inc., a clinical stage biopharmaceutical company, develops small molecule precision medicines for the treatment of renal, cardiovascular, related metabolic diseases, and obesity in the United States. Its lead programs includes MZE829, an oral small molecule inhibitor of apolipoprotein L1, which is in phase II clinical trial for the treatment of patients with APOL1 kidney disease; and MZE782, an oral small molecule inhibitor of the solute transporter SLC6A19, which is in phase I clinical trial for the treatment of chronic kidney disease. Maze Therapeutics, Inc. was formerly known as Modulus Therapeutics, Inc. and changed its name to Maze Therapeutics, Inc. in September 2018. The company was incorporated in 2017 and is based in South San Francisco, California.
MAZE Financial Timeline
Browse a chronological timeline of Maze Therapeutics, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 11 Nov 2025
EPS estimate is -$0.79.
Earnings released on 12 Aug 2025
EPS came in at -$0.77 surpassing the estimated -$0.79 by +2.53%.
Earnings released on 14 May 2025
EPS came in at -$1.15 falling short of the estimated -$0.76 by -51.32%.
Earnings released on 31 Mar 2025
EPS came in at -$18.32 falling short of the estimated $0.45 by -4.17K%.
Earnings released on 30 Sept 2024
EPS came in at -$0.57 , while revenue for the quarter reached $2.50M .
Earnings released on 30 Jun 2024
EPS came in at $3.18 , while revenue for the quarter reached $165.00M .
Earnings released on 31 Mar 2024
EPS came in at -$0.74 .
Earnings released on 31 Dec 2023
EPS came in at -$0.61 .
Earnings released on 30 Sept 2023
EPS came in at -$0.57 .
MAZE Stock Performance
Access detailed MAZE performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.